Hypertensive Medications and Reduced Colorectal Cancer Risk: Wai K. Leung, MD

In this interview, Wai K. Leung, MD, speaks with i3 Health about his research team's finding, recently published in Hypertension, that angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are associated with a decreased risk of colorectal cancer within three years of colonoscopy. Dr. Leung discusses the significance of the study's results and shares potential reasons behind the link between ACE inhibitor and ARB use and reduced colorectal cancer risk. Can you c...
Continue reading

Colorectal Cancer: Common Blood Pressure Medications May Reduce Risk

Taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is associated with a decreased risk of colorectal cancer within three years of colonoscopy, according to the results of a new study. By inhibiting or blocking angiotensin, a protein that raises blood pressure by constricting the arteries, ACE inhibitors and ARBs treat heart disease, heart failure, and high blood pressure. Whether ACE inhibitors and ARBs can also play a role in cancer prevention, howeve...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.